Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene® Mist
/
Date27 Dec 2016
RANCHO CUCAMONGA, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration (FDA) issued a... Read More →
Global Angioplasty Balloons Market will reach $2.41 billion by 2021: Zion Market Research
/
Date27 Dec 2016
Sarasota, FL, Dec. 27, 2016 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Angioplasty Balloons Market by Product (Drug Eluting Balloons,... Read More →
Vision Therapy at Complete Eye Care of Medina Improves Children’s School Performance
/
Date26 Dec 2016
MEDINA, Minn., Dec. 26, 2016 (GLOBE NEWSWIRE) — Blurry vision or perceptual problems with reading harm a child’s ability to learn and an adult’s ability... Read More →
Back To Health Family Chiropractic Aims to Help Fort Worth Families Stay Healthy Through Winter
/
Date26 Dec 2016
FORT WORTH, Texas, Dec. 26, 2016 (GLOBE NEWSWIRE) — Back To Health Family Chiropractic would like to inform the Fort Worth community about how regular... Read More →
Global Fitness Equipment Market will reach $12.50 Billion by 2021: Zion Market Research
/
Date26 Dec 2016
Sarasota, FL, Dec. 26, 2016 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Fitness Equipment Market by Equipment Type (Cardio-Respiratory Equipment,... Read More →
Global Stroke Diagnostics and Therapeutics Market Size to reach USD 31.00 Billion by 2021: Zion Market Research
/
Date26 Dec 2016
Sarasota, FL, Dec. 26, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Stroke Diagnostics and Therapeutics Market by Diagnostics (Magnetic Resonance... Read More →
TiGenix: notification concernant les obligations convertibles arrivant à échéance en 2018
/
Date23 Dec 2016
NOTIFICATION TiGenix: notification concernant les obligations convertibles arrivant à échéance en 2018 Louvain (BELGIQUE) – le 23 décembre 2016, 22:01h CET – TiGenix NV (Euronext... Read More →
TiGenix: notice in relation to the convertible bonds due 2018
/
Date23 Dec 2016
NOTICE TiGenix: notice in relation to the convertible bonds due 2018 Leuven (BELGIUM) – December 23, 2016, 22:01h CET – TiGenix NV (Euronext Brussels and... Read More →
TiGenix: kennisgeving in verband met de converteerbare obligaties met vervaldatum in 2018
/
Date23 Dec 2016
KENNISGEVING TiGenix: kennisgeving in verband met de converteerbare obligaties met vervaldatum in 2018 Leuven (BELGIE) – 23 december 2016, 22:01u CET – TiGenix NV (Euronext... Read More →
Portola Pharmaceuticals Announces FDA Accepts New Drug Application for Priority Review and EMA Validates Marketing Authorization Application for Oral, Factor Xa Inhibitor Anticoagulant Betrixaban
/
Date23 Dec 2016
SOUTH SAN FRANCISCO, Calif., Dec. 23, 2016 (GLOBE NEWSWIRE) — Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA) accepted... Read More →